Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
1 clinical trials · Condition
◉ Watch Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET) (NCT02288377) | Federation Francophone de Cancerologie Digestive | 2015-01-01 |
Track Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours automatically
Every clearance here is in the API, with alerts when new ones post.